What is NDC 69238-1123?

69238-1123 is the product NDC for Nadolol, Nadolol 20 mg/1 tablet, listed with the FDA by Amneal Pharmaceuticals NY LLC. It has 3 package NDCs, shown above in 10- and 11-digit form.

Amneal Pharmaceuticals NY LLC, NDC labeler code 69238. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Nadolol?

52 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Nadolol NDC 69238-1123 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)69238-1123Labeler and product segments. Claims need a package NDC.

Product NDC at billing width69238-1123Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
69238-1123-1	69238112301	1000 TABLET in 1 BOTTLE (69238-1123-1)Marketed from Jun 2, 2017
69238-1123-3	69238112303	30 TABLET in 1 BOTTLE (69238-1123-3)Marketed from Jun 2, 2017
69238-1123-9	69238112309	90 TABLET in 1 BOTTLE (69238-1123-9)Marketed from Jun 2, 2017

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Nadolol
Generic name (nonproprietary): nadolol
Active ingredients: Nadolol — 20 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Amneal Pharmaceuticals NY LLCNDC labeler code 69238
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 208832
Marketing start: Jun 2, 2017
Listing expires: Dec 31, 2027
Other FDA classes: Adrenergic beta-Antagonists (Mechanism)
Identifiers: Product ID 69238-1123_c6c87588-2b1f-4319-97bf-d045e884a80fSPL ID c6c87588-2b1f-4319-97bf-d045e884a80fSPL set ID e2e24b14-0169-4028-828a-894ad3c2ba55RxCUI 198006, 198007, 198008UNII FEN504330VUPC 0369238112535, 0369238112436
Pharmacologic class: beta-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N469238112301 followed by a unit qualifier and the quantity

Package 69238-1123-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 12, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Angina Pectoris Nadolol tablets are indicated for the long-term management of patients with angina pectoris. Hypertension Nadolol tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. There are no controlled trials demonstrating risk reduction with nadolol tablets. Control of high blood pressure should be part of comprehensive cardiov…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 69238-1123

What is NDC 69238-1123?: 69238-1123 is the product NDC for Nadolol, Nadolol 20 mg/1 tablet, listed with the FDA by Amneal Pharmaceuticals NY LLC. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Nadolol.
What is the active ingredient?: Nadolol.
Who is the labeler?: Amneal Pharmaceuticals NY LLC, NDC labeler code 69238. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Nadolol?: 52 other product NDCs are listed under this name. See all Nadolol NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Nadolol NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Nadolol	Nadolol 40 mg/1	TabletOral	REMEDYREPACK INC.	70518-4662	70518-4662-00
Nadolol	Nadolol 40 mg/1	TabletOral	BluePoint Laboratories	68001-691	68001-0691-00
Nadolol	Nadolol 20 mg/1	TabletOral	BluePoint Laboratories	68001-690	68001-0690-00
Nadolol	Nadolol 80 mg/1	TabletOral	BluePoint Laboratories	68001-692	68001-0692-00
Nadolol	Nadolol 20 mg/1	TabletOral	American Health Packaging	60687-887	60687-0887-21
Nadolol	Nadolol 40 mg/1	TabletOral	American Health Packaging	60687-898	60687-0898-21
Nadolol	Nadolol 20 mg/1	TabletOral	BluePoint Laboratories	68001-630	68001-0630-00
Nadolol	Nadolol 40 mg/1	TabletOral	BluePoint Laboratories	68001-631	68001-0631-00
Nadolol	Nadolol 80 mg/1	TabletOral	BluePoint Laboratories	68001-632	68001-0632-00
Nadolol	Nadolol 20 mg/1	TabletOral	Alembic Pharmaceuticals Limited	46708-402	46708-0402-3046708-0402-3146708-0402-91

All 53 Nadolol NDCs

Other NDCs under ANDA 208832

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 208832
Product	Strength	Form · route	Labeler	Product NDC
Nadolol	Nadolol 40 mg/1	TabletOral	Amneal Pharmaceuticals NY LLC	69238-1124
Nadolol	Nadolol 80 mg/1	TabletOral	Amneal Pharmaceuticals NY LLC	69238-1125
Nadolol	Nadolol 20 mg/1	TabletOral	A-S Medication Solutions	50090-7995